0 Evaluaciones

ID

20421

Descripción

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Palabras clave

  1. 22/2/17 22/2/17 -
Subido en

22 de febrero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Trial Completion
    Descripción

    Trial Completion

    Alias
    UMLS CUI-1
    C2732579 (Completion of clinical trial)
    SNOMED
    443729008
    1. The patient completed planned observation time according to protocol
    Descripción

    patient completed planned observation time

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0525058 (Protocol Compliance)
    UMLS CUI [1,2]
    C0040223 (Time)
    SNOMED
    410670007
    LOINC
    LP73517-2
    2. If no please specify why:
    Descripción

    if no

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C2348235 (Specification)
    Explain:
    Descripción

    Explanation

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0681841 (Explanation)
    LOINC
    LA15331-4
    Invenstigator´s Declaration
    Descripción

    Invenstigator´s Declaration

    Alias
    UMLS CUI-1
    C0008961 (Clinical Investigators)
    3. Invenstigator´s Declaration By signing and dating this page, I declare that I have reviewed for accuracy all case report form pages for this patient; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed in the dates specified.
    Descripción

    Invenstigator´s Declaration

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0008961 (Clinical Investigators)
    UMLS CUI [1,2]
    C1442085 (Instructions)
    LOINC
    LP6820-7
    Investigator´s signature
    Descripción

    Investigator´s signature

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C2346576 (Investigator Signature)
    Date of Signature
    Descripción

    Date of Signature

    Tipo de datos

    date

    Alias
    UMLS CUI [1,1]
    C0011008 (Date in time)
    SNOMED
    410671006
    UMLS CUI [1,2]
    C1519316 (Signature)
    LOINC
    LP248948-4

    Similar models

    Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Trial Completion
    C2732579 (UMLS CUI-1)
    patient completed planned observation time
    Item
    1. The patient completed planned observation time according to protocol
    boolean
    C0525058 (UMLS CUI [1,1])
    C0040223 (UMLS CUI [1,2])
    Item
    2. If no please specify why:
    integer
    C2348235 (UMLS CUI [1])
    Code List
    2. If no please specify why:
    CL Item
    Death (must me recorded on death form) (1)
    CL Item
    Adverse Event (explain below) (2)
    CL Item
    Non compliant with protocol (explain below) (3)
    CL Item
    Lost follow-up (explain below) (4)
    CL Item
    Consent withdrawn (not due to adverse event, explain below) (5)
    CL Item
    Other (explain below) (6)
    Explanation
    Item
    Explain:
    text
    C0681841 (UMLS CUI [1])
    Item Group
    Invenstigator´s Declaration
    C0008961 (UMLS CUI-1)
    Invenstigator´s Declaration
    Item
    3. Invenstigator´s Declaration By signing and dating this page, I declare that I have reviewed for accuracy all case report form pages for this patient; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed in the dates specified.
    text
    C0008961 (UMLS CUI [1,1])
    C1442085 (UMLS CUI [1,2])
    Investigator´s signature
    Item
    Investigator´s signature
    text
    C2346576 (UMLS CUI [1])
    Date of Signature
    Item
    Date of Signature
    date
    C0011008 (UMLS CUI [1,1])
    C1519316 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial